NKTR Crosses Above Average Analyst Target Thursday, February 18, 8:26 AM ET, by Market News Video Staff In recent trading, shares of Nektar Therapeutics (NKTR) have crossed above the average analyst 12-month ...
NKTR April 23rd Options Begin Trading Thursday, March 4, 11:38 AM ET, by Market News Video Staff Investors in Nektar Therapeutics (NKTR) saw new options become available today, for the April 23rd ...
Investors in Nektar Therapeutics (NASDAQ:NKTR) saw new options become available today, for the June 4th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NKTR options chain for the new June 4th contracts and identified one put and one call contract of particular interest.
The put contract at the $19.50 strike price has a current bid of 80 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $19.50, but will also collect the premium, putting the cost basis of the shares at $18.70 (before broker commissions). To an investor already interested in purchasing shares of NKTR, that could represent an attractive alternative to paying $20.13/share today.
Because the $19.50 strike represents an approximate 3% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 100%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 4.10% return on the cash commitment, or 34.82% annualized — at Stock Options Channel we call this the YieldBoost.
Below is a chart showing the trailing twelve month trading history for Nektar Therapeutics, and highlighting in green where the $19.50 strike is located relative to that history:
Turning to the calls side of the option chain, the call contract at the $21.00 strike price has a current bid of 75 cents. If an investor was to purchase shares of NKTR stock at the current price level of $20.13/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $21.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 8.05% if the stock gets called away at the June 4th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if NKTR shares really soar, which is why looking at the trailing twelve month trading history for Nektar Therapeutics, as well as studying the business fundamentals becomes important. Below is a chart showing NKTR's trailing twelve month trading history, with the $21.00 strike highlighted in red:
Considering the fact that the $21.00 strike represents an approximate 4% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 3.73% boost of extra return to the investor, or 31.63% annualized, which we refer to as the YieldBoost.
Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $20.13) to be 47%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
This Article's Word Cloud:ArialBelowChannelConsideringJuneNKTRNektarOptionsShouldStartStockStrikeTherapeuticsYieldBoostafterLeftLabelsalsocallchartcontractcoveredcurrentexpirefillColorgreekshistoryinvestorleftmonthoddsoptionspremiumpricerepresentreturnsellsharesstockstrikethattheythisthosetodaytradingtrailingtwelvewhichwillworthlesswould
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.